| Patent | Date |
|---|
Methods For Treating Idiopathic Pulmonary Fibrosis
App 20220151581 - PORTER; Seth ; et al. | 2022-05-19 |
Methods For Treating Idiopathic Pulmonary Fibrosis
App 20200113533 - PORTER; Seth ; et al. | 2020-04-16 |
Methods for treating idiopathic pulmonary fibrosis
Grant 10,555,713 - Porter , et al. Feb | 2020-02-11 |
Composition For Administering An Nmda Receptor Antagonist To A Subject
App 20190201354 - WENT; Gregory T. ; et al. | 2019-07-04 |
Methods Of Treating Idiopathic Pulmonary Fibrosis
App 20190127456 - Porter; Seth ; et al. | 2019-05-02 |
Composition For Administering An Nmda Receptor Antagonist To A Subject
App 20190008799 - WENT; Gregory T. ; et al. | 2019-01-10 |
Methods For Treating Idiopathic Pulmonary Fibrosis
App 20180310906 - Porter; Seth ; et al. | 2018-11-01 |
Methods for treating idiopathic pulmonary fibrosis
Grant 10,039,515 - Porter , et al. August 7, 2 | 2018-08-07 |
Composition for Administering an NMDA Receptor Antagonist to a Subject
App 20170281565 - Went; Gregory T. ; et al. | 2017-10-05 |
Composition for Administering an NMDA Receptor Antagonist to a Subject
App 20170056340 - Went; Gregory T. ; et al. | 2017-03-02 |
Methods For Treating Idiopathic Pulmonary Fibrosis
App 20170027535 - PORTER; SETH ; et al. | 2017-02-02 |
Methods for treating idiopathic pulmonary fibrosis
Grant 9,480,449 - Porter , et al. November 1, 2 | 2016-11-01 |
Therapeutic method
Grant 9,102,721 - Neff , et al. August 11, 2 | 2015-08-11 |
Methods For Treating Idiopathic Pulmonary Fibrosis
App 20150086483 - Porter; Seth ; et al. | 2015-03-26 |
Composition and method for treating neurological disease
Grant 8,987,333 - Went , et al. March 24, 2 | 2015-03-24 |
Composition And Method For Treating Neurological Disease
App 20140356425 - Went; Gregory T. ; et al. | 2014-12-04 |
Composition and method for treating neurological disease
Grant 8,895,618 - Went , et al. November 25, 2 | 2014-11-25 |
Composition and method for treating neurological disease
Grant 8,895,615 - Went , et al. November 25, 2 | 2014-11-25 |
Composition and method for treating neurological disease
Grant 8,895,614 - Went , et al. November 25, 2 | 2014-11-25 |
Composition and method for treating neurological disease
Grant 8,895,616 - Went , et al. November 25, 2 | 2014-11-25 |
Composition and method for treating neurological disease
Grant 8,895,617 - Went , et al. November 25, 2 | 2014-11-25 |
Composition And Method For Treating Neurological Disease
App 20140343164 - Went; Gregory T. ; et al. | 2014-11-20 |
Composition And Method For Treating Neurological Disease
App 20140343163 - Went; Gregory T. ; et al. | 2014-11-20 |
Composition And Method For Treating Neurological Disease
App 20140343153 - Went; Gregory T. ; et al. | 2014-11-20 |
Composition And Method For Treating Neurological Disease
App 20140343154 - Went; Gregory T. ; et al. | 2014-11-20 |
Composition And Method For Treating Neurological Disease
App 20140343152 - Went; Gregory T. ; et al. | 2014-11-20 |
Composition and method for treating neurological disease
Grant 8,889,740 - Went , et al. November 18, 2 | 2014-11-18 |
Composition And Method For Treating Neurological Disease
App 20140323582 - Went; Gregory T. ; et al. | 2014-10-30 |
Composition and method for treating neurological disease
Grant 8,796,337 - Went , et al. August 5, 2 | 2014-08-05 |
Composition for Administering an NMDA Receptor Antagonist to a Subject
App 20140179797 - Went; Gregory T. ; et al. | 2014-06-26 |
Therapeutic Method
App 20140127224 - Neff; Thomas B. ; et al. | 2014-05-08 |
Composition and Method for Treating Neurological Disease
App 20130317115 - Went; Gregory T. ; et al. | 2013-11-28 |
Composition and Method for Treating Neurological Disease
App 20130165517 - Went; Gregory T. ; et al. | 2013-06-27 |
Method and composition for administering an NMDA receptor antagonist to a subject
Grant 8,426,472 - Went , et al. April 23, 2 | 2013-04-23 |
Composition and method for treating neurological disease
Grant 8,389,578 - Went , et al. March 5, 2 | 2013-03-05 |
Method and composition for administering an NMDA receptor antagonist to a subject
Grant 8,168,209 - Went , et al. May 1, 2 | 2012-05-01 |
Method And Composition For Administering An Nmda Receptor Antagonist To A Subject
App 20120058182 - Went; Gregory T. ; et al. | 2012-03-08 |
Method And Composition For Administering An Nmda Receptor Antagonist To A Subject
App 20120045508 - Went; Gregory T. ; et al. | 2012-02-23 |
Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
App 20120046365 - Went; Gregory T. ; et al. | 2012-02-23 |
Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
App 20110059169 - Went; Gregory T. ; et al. | 2011-03-10 |
Method And Composition For Administering An Nmda Receptor Antagonist To A Subject
App 20100266684 - Went; Gregory T. ; et al. | 2010-10-21 |
Method And Composition For Administering An Nmda Receptor Antagonist To A Subject
App 20100260838 - Went; Gregory T. ; et al. | 2010-10-14 |
Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
App 20100047342 - Went; Gregory T. ; et al. | 2010-02-25 |
Composition and method for treating neurological disease
App 20060189694 - Went; Gregory T. ; et al. | 2006-08-24 |
Method and composition for adminstering an NMDA receptor antagonist to a subject
App 20060142398 - Went; Gregory T. ; et al. | 2006-06-29 |
Blood-brain barrier model
Grant 5,260,210 - Rubin , et al. November 9, 1 | 1993-11-09 |
| 